Table 2.
Country | 2017–2018 | 2018–2019 | 2019–2020 | Average Pre-pandemic | 2021–2022 | 2022–2023 | ||
---|---|---|---|---|---|---|---|---|
No. (% RSV/ARI) | No. (% RSV/ARI) | No. (% RSV/ARI) | No. (% RSV/ARI) | No. (% RSV/ARI) | Relative Change | No. (% RSV/ARI) | Relative Change | |
Scotland | ||||||||
ARI hospitalizations | 999 | 1168 | 959 | 1042 | 1067 | 1.02 | 1373 | 1.32 |
RSV hospitalizations | 303 (30.3%) | 303 (25.9%) | 361 (37.6%) | 322 (30.9%) | 306 (28.7%) | 0.95 | 455 (33.1%) | 1.41 |
Spain | ||||||||
ARI hospitalizations | 208 | 198 | 168 | 191 | 140 | 0.73 | 343 | 1.80 |
RSV hospitalizations | 88 (42.3%) | 96 (48.5%) | 80 (47.6%) | 88 (46.1%) | 56 (40%) | 0.64 | 170 (49.6%) | 1.93 |
Finland | ||||||||
ARI hospitalizations | 353 | 282 | 262 | 299 | 390 | 1.30 | 600 | 2.01 |
RSV hospitalizations | 99 (28.0%) | 55 (19.5%) | 85 (32.4%) | 80 (26.8%) | 111 (28.5%) | 1.39 | 181 (30.2%) | 2.26 |
The Netherlands | ||||||||
ARI hospitalizations | 246 | 222 | 175 | 214 | 210 | 0.98 | 260 | 1.21 |
RSV hospitalizations | 74 (30.1%) | 52 (23.4%) | 55 (31.4%) | 60 (28.0%) | 80 (38.1%) | 1.33 | 121 (46.5%) | 2.02 |
Abbreviations: ARI, acute respiratory infection; RSV, respiratory syncytial virus.